Velocity Clinical Research, Berlin
Founded in 2002 as Klinische Forschung Berlin GbR and acquired by Velocity Clinical Research in 2023, the experienced team at Velocity’s dedicated research site in Berlin conducts clinical trials across a broad variety of indications. The site has three investigators who specialize in internal medicine and cardiology.
Our Berlin team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research. With decades of research experience shared among our investigators in Berlin, Velocity will deliver the right patients, investigators, and research staff for your next research program.
Velocity Clinical Research, Berlin
Ansbacher Straße 17, 10787, Berlin, Germany
Phone: +49 30 20859400
Find a Clinical Trial in Berlin
Sign up below to speak with an enrollment specialist about available research studies in Berlin.
Follow Velocity on Facebook for company updates and more.
Our experienced research team in Berlin
Every clinical trial is overseen by a Principal Investigator – a physician who is responsible for the rights, safety and welfare of the study participants. All physicians at Velocity are board certified in their specialty area(s) and all research staff is trained in clinical research regulations, including GCP and HIPAA. Our clinical research team in Berlin is dedicated to conducting quality research in a professional and caring environment.
Isabelle Schenkenberger, MD, has been an Internal Medicine Specialist since 2000, and has practiced at her own clinic since 2002. She studied human medicine at both the Albert-Ludwigs-University of Freiburg and the Free University of Berlin. After graduating, she worked at the Auguste-Viktoria-Klinikum in internal medicine with a focus on cardiology, angiology, diabetology and emergency medicine from 1990 to 2004. Dr. Schenkenberger has also served as a Principal Investigator since 1999.
Tilman Dreykluft, MD has been an internal medicine and cardiology specialist since 1992. He studied human medicine at the Free University of Berlin before working in an internal medicine department with a focus on invasive cardiology and intensive care medicine. He has been a Cardiologist in private practice at Kardios since 2006. Dr. Dreykluft has also served as a Principal Investigator since 1996.
Thomas Zöller, MD has practiced in internal medicine and cardiology since 1990, after studying human medicine at the Free University of Berlin. He worked in a conservative and invasive cardiology department with a focus on cardiology and emergency medicine before transitioning to practicing as a Cardiologist at Kardios in 2006. Dr. Zöller has also served as a Principal Investigator since 1998.
Katrein Dreykluft is a state-certified nurse since 1990, after graduating from the University Hospital Charité. She also studied business administration at the Free University of Berlin, going on to work as a freelancer in health care at KPMG, and as a lecturer in health care and IT. Katrein later began her own clinical research site, Klinische Forschung Berlin GbR in 2002, which was acquired by Velocity in 2023.
Complete the form to start your clinical trial journey in Berlin
Beyond helping advance medicine, you may also:
- Get care from a local doctor at no cost
- Learn about new medicines in development
- Receive study-related medical exams at no cost
- Get paid for participating (amounts differ for each study)
After you submit your info, a Velocity staff member will review your info. They will contact you to talk about the study, or others that may be right for you.
Health insurance is generally not needed to join a clinical trial.
Remember, there is never an obligation to join — we're here to help you make the best decision.
Submit your info
Sponsors and CROs
From the leading pharma companies, to the most pioneering biotech startups, Velocity supports those who are exploring new frontiers in human health. Whether you’re ready to conduct a single-site study or a complex, high-volume clinical trial, trust Velocity.